Fractional flow reserve substitutes in aortic stenosis

EuroIntervention 2020;16:e273-e275. DOI: 10.4244/EIJV16I4A46

Nils Johnson
Nils P. Johnson1, MD, MS; Pim A.L. Tonino2, MD, PhD
1. Weatherhead PET Center, Division of Cardiology, Department of Medicine, McGovern Medical School at UTHealth and Memorial Hermann Hospital, Houston, TX, USA; 2. Department of cardiology, Catharina Hospital, Eindhoven, the Netherlands

“Accept no substitutes!”. Does this slogan belong solely to the domain of the advertiser, or might it apply to medicine beyond generic drug substitutions at the pharmacy? The QASTA study, published in this issue of EuroIntervention1, demands that we address the question in regard to coronary physiology for patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI).

In that study, 138 lesions from 7 centres in 5 countries underwent fractional flow reserve (FFR) assessment as part of the TAVI workup, then post hoc analysis of the angiograms to compute the quantitative flow ratio (QFR). Does QFR provide ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Drug-coated balloon angioplasty for in-stent restenosis – a question of the right device or the right patient selection and technique?

Latest news